HSPG2 and mucopolysaccharidosis: Finally, we recently developed an innovative HSPG-targeting strategy for the cure of some MPS subtypes, inherited human diseases characterized by the accumulation of an excess of the cell surface and extracellular HS leading to the loss of cellular functions, tissue damage, and organ dysfunctions [174].